Cellular Signaling in Metabolic Disease – Dysregulation to Disorder

The Scientist is bringing together a panel of experts to discuss the methods they use for isolating and investigating these multifaceted pathways, and to share the findings of their latest research. 

By | September 6, 2016

 

FREE Webinar

Tuesday, October 18, 2016
2:30 - 4:00 p.m. Eastern Time
View The Video Now

Metabolic pathways represent the beautifully orchestrated interplay between cellular systems, working in concert to achieve a shared goal, but – despite their power when finely tuned – they can rapidly fall out of sync, giving rise to disease. To better understand the genesis of these diseases and, ultimately, how to reverse or prevent them, researchers are interrogating the integral cell-signaling pathways and assessing their defects. The Scientist is bringing together a panel of experts to discuss the methods they use for isolating and investigating these multifaceted pathways, and to share the findings of their latest research. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

View The Video Now

Meet the Speakers:

Nathan P. Coussens, PhD
Senior Research Scientist, Biology
Division of Pre-Clinical Innovation
National Center for Advancing Translational Sciences
National Institutes of Health

 

Beatrice Haimovich, PhD
Associate Professor of Surgery
RW Johnson Medical School
Rutgers University

 

Lisa Stehno-Bittel, PhD
President
Likarda, LLC

 

PerkinElmer

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  2. Authors Peeved by APA’s Article Takedown Pilot
  3. Athletes’ Microbiomes Differ from Nonathletes
  4. Was a Drop in CRISPR Firms’ Stock Warranted?
AAAS